26 reports of this reaction
1.7% of all ALLOPURINOL SODIUM reports
#8 most reported adverse reaction
DIZZINESS is the #8 most commonly reported adverse reaction for ALLOPURINOL SODIUM, manufactured by Hikma Pharmaceuticals USA Inc.. There are 26 FDA adverse event reports linking ALLOPURINOL SODIUM to DIZZINESS. This represents approximately 1.7% of all 1,553 adverse event reports for this drug.
Patients taking ALLOPURINOL SODIUM who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for ALLOPURINOL SODIUM, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for ALLOPURINOL SODIUM:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 26 FDA reports for ALLOPURINOL SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 1.7% of all adverse event reports for ALLOPURINOL SODIUM, making it a notable side effect.
If you experience dizziness while taking ALLOPURINOL SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.